If the arrhythmia does not terminate within 10 minutes after the end of the initial infusion , a second 10-minute infusion of equal strength may be administered 10 minutes after completion of the first infusion. Patients should be observed with continuous EGG monitoring for at least 4 hours following infusion or until QTc has returned to baseline. Longer monitoring is required if any arrhythmic activity is noted. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Strict adherence to the use of aseptic technique during the preparation of the admixture is recommended in order to maintain sterility.
Federal law prohibits dispensing without prescription.